Hi [[ session.user.profile.firstName ]]

Medical Research

  • USP : Methods for Moisture Determination and Karl Fisher Titration
    USP : Methods for Moisture Determination and Karl Fisher Titration Bruce Herzig, Sr. Application Scientist, Merck KGaA, Darmstadt, Germany Recorded: Dec 7 2017 32 mins
    Many Pharmacopeia materials contain water as hydrates or in adsorbed form. Therefore the determination of the water content is important to maintaining compliance with the Pharmacopeia guidelines. Generally one of the three methods are given in the monographs, Method I (Titrimetric), Method II (Azeotropic), or Method III (Gravimetric). This poster will discuss the application of these methods to moisture determinations focusing on Karl Fischer techniques.
  • SPME Applications in Food Analysis by means of a New Matrix Compatible Coating
    SPME Applications in Food Analysis by means of a New Matrix Compatible Coating Emanuela Gionfriddo, Ph.D.; Research Associate under Prof. Janusz Pawliszyn, University of Waterloo (ON, Canada) Recorded: Dec 7 2017 65 mins
    The complexity and diversity of food matrices, and the need for clean extracts to be injected into analytical instrumentation may imply the use of tedious and time-consuming sample preparation strategies that often produce significant laboratory waste. The development of a new matrix-compatible solid phase microextraction (SPME) coating, namely PDMS/DVB/PDMS, bearing enhanced antifouling properties, enables the analysis of complex food matrices by direct immersion SPME, and helps to overcome issues related to extensive sample pre-treatment and instrumental contamination. This webinar will focus on recent advances made toward the analysis of contaminants in complex food samples by using the new matrix-compatible SPME coating, and will describe the optimization of important parameters to be considered when performing Direct Immersion SPME (DI-SPME).
  • Publishing your Research: Enhancing Transparency and Rigor
    Publishing your Research: Enhancing Transparency and Rigor Natalia Ortuzar and Eric M. Prager Recorded: Dec 6 2017 58 mins
    Publish with integrity! This webinar will explore strategies to ensure your scientific findings meet the necessary standards of transparency and reproducibility and achieve the highest impact within the scientific community. Experts in the field of neuroscience will provide targeted presentations followed by a Q&A.

    Speakers:
    Dr. Natalia Ortuzar is the Associate Editorial Director for Wiley-owned life and physical sciences journals in North America. Her team works on over 80 journals, covering topics from neuroscience and cell biology through to engineering and statistics. With a decade of publishing experience, Natalia has a background in open-access publishing and expertise in copyright and publishing ethics, as well as an intimate knowledge of the publishing process, from submission through peer review to production and post-publication, as an author, reviewer, and editor.

    Dr. Prager is the Editor-in-Chief for the Journal of Neuroscience Research and the Developmental Editor for Current Protocols in Neuroscience and Current Protocols in Toxicology. Dr. Prager earned his Ph.D. from the Uniformed Services University in Neuroscience, where he investigated the long-term consequences of a nerve agent exposure. Cooperating with groups from the NIH and the National Centre for the Replacement, Refinement & Reduction of Animals in Research, Dr. Prager has developed new guidelines to promote transparent science and increase reproducibility of published research.
  • Evolution and Adoption of Biometrics
    Evolution and Adoption of Biometrics Niosha Kayhani | Cubics and Ruta Sudmantaite from PatSnap Recorded: Dec 6 2017 41 mins
    Biometrics has slowly become more and more present in our everyday lives. We no longer bat an eyelid when our phones require us to use a finger print for a payment or even when its how you get into your gym. So whats the next step?

    Cubic, who are the people behind the payment technology of the London Transport System, have devised a system that can double the “throughput” of an entrance—from 25 people crossing a gate’s threshold per minute, to about 50 or 60. This idea could mean that we would no longer have gates at tube stations across London and instead your phone in combination with your face.

    Niosha Kayhani of Cubic will be taking us through the development of this Technology and also the growing uses and industry that is Biometrics.
  • Computer Algebra for Theoretical Physics
    Computer Algebra for Theoretical Physics Edgardo Cheb-Terrab, Research Fellow, Maplesoft Recorded: Dec 6 2017 60 mins
    Generally speaking, physicists still find that computing with paper and pencil is in most cases simpler than computing with a Computer Algebra System (CAS). Although that is true in some cases, the working paradigm is changing: developments in CAS, and particularly recent ones in the Maple system, have resulted in the implementation of most of the mathematical objects and mathematics used in theoretical physics computations, and have dramatically approximated the notation used in the computer to the one used with paper and pencil, diminishing the learning gap and computer-syntax distraction to a strict minimum. In this talk, the Physics project at Maplesoft will be presented and the resulting Physics package will be illustrated through simple problems in classical field theory, quantum mechanics and general relativity, and through tackling the computations of some recent Physical Review papers in those areas.
  • R&D Investments and Digitization Propel Growth of Diagnostic Solutions in Asia
    R&D Investments and Digitization Propel Growth of Diagnostic Solutions in Asia Rhenu Bhuller, Partner & Sanjeev Kumar, Industry Manager (Frost & Sullivan), Dr. Allen Lai, SVP of ACT Genomics Singapore Recorded: Dec 6 2017 58 mins
    The industry is being disrupted by integration of the multi-disciplinary capabilities in biology, chemistry and computational power that companies can leverage to develop new solutions to diagnose, treat and manage chronic disease conditions, such as cancer, cardiovascular disease and diabetes. There is immense pressure on companies to build competencies in product development, manufacturing and distribution of new technology platforms such as point-of-care molecular diagnostics to capture new growth opportunities in the precision medicine market—a paradigm shift that will transform clinical practice and treatment outcomes.
  • IOP ebooks - Meet the author Dr Tristan Kershaw
    IOP ebooks - Meet the author Dr Tristan Kershaw Dr Tristan Kershaw Recorded: Dec 4 2017 45 mins
    Join us for this very timely webinar with Dr Tristan Kershaw as he gives an overview of his book Climate Change Resilience in the Urban Environment. This new book is one of the first to look at the resilience of whole cities as the world’s population changes from 70% rural to 70% urban in the space of just 100 years. It looks at risks for urban areas, including those risks to human health as well as building integrity.

    The webinar will last 45 minutes and will include a live Q&A session.
  • Peer Review: discover more about the process and outcomes
    Peer Review: discover more about the process and outcomes Dr Andrew Moore Recorded: Dec 1 2017 48 mins
    As a researcher do you ever have the following questions about peer review when looking to publish your research?
    •Why is peer review important?
    •How does the peer review process work?
    •What does a reviewer look like?
    •How does a journal editor use peer review?
    Join us for our live webinar clinic and learn all you need to know about the role of peer review within the publishing process. Learn from and interact with the Editor-In-Chief for the Wiley Researcher Academy, Dr Andrew Moore. You’ll have the chance to ask questions during the live Q&A sessions and connect with other researchers in the BrightTalk community.
    Are you interested in comprehensive coverage of all the major challenges facing you when publishing your scientific articles? This webinar will also include an introduction and overview of the Wiley Researcher Academy, a comprehensive, 50 hour training course covering all aspects of the publishing process as well as a detailed look at the skills and attributes of successful researchers.
  • Characterization of sub-visible particles with Amnis imaging flow cytometry
    Characterization of sub-visible particles with Amnis imaging flow cytometry Christine Probst, Application Scientist - Merck KGaA, Darmstadt, Germany Recorded: Nov 30 2017 43 mins
    Multi-spectral imaging flow cytometry (MIFC) is an established analytical method for cellular analysis, however has only recently been evaluated for characterization of sub-visible particles in therapeutic formulations despite numerous favorable attributes including:

    • Simultaneous collection of bright-field, side-scatter, and fluorescent imagery
    • Sensitive detection of particles 100 nm-100 μm
    • High image quality using 20X-60X magnification objectives
    • 100% sampling efficiency using hydrodynamic focusing
    • Small sample volume requirement (20 μL)
    • Linear concentration range up to 100 million/mL
    • Wide flow cell (250 μm) minimizes clogs

    Assorted case studies using MIFC for analysis of protein and vaccine formulations will be presented, with an emphasis on measurements and samples that pose challenges for current techniques- including detection of small and transparent particles, direct analysis of highly concentrated formulations, and fluorescence characterization of particle type, chemical composition, and heterogeneous interactions.
  • The Future of Marketing in Life Sciences: Is your function fit for purpose?
    The Future of Marketing in Life Sciences: Is your function fit for purpose? Dominic Tyer Recorded: Nov 30 2017 54 mins
    The healthcare landscape is rapidly changing as it responds to a multitude of well-known issues. Coupled with emerging digital technologies, these drivers are shaping the industry, moving it towards a more sophisticated, outcomes-driven model that demands a new approach. The new world emerging is one in which value is defined, created and evaluated in a very different way, with marketing playing a critical role.

    On 30 November, EY (a global leader in assurance, tax, transaction and advisory services) in association with PMGroup, will host a free webinar debating the future of marketing in Life Sciences. Is your function fit for purpose?
  • Improving commercial decisions with customer relationship network insights
    Improving commercial decisions with customer relationship network insights Megan Oh (Abbott), Leilani Latimer (Zephyr Health), Paul Tunnah (pharmaphorum) Recorded: Nov 28 2017 62 mins
    Networks of influence are shifting the decision-making process for life sciences companies. It is no longer enough to simply view the profile of a HCP or HCO to understand their value to your organization.

    For life sciences organizations, there is currently a gap in information, understanding, and digital access to these critical customer networks and relationships.

    Relying solely on internal knowledge, field experience or purchased data provides an analog, one-dimensional view of these networks. This limits companies from fully understanding key influencers, referral pathways, speaker and authorship networks and more, which once uncovered can significantly influence customer outreach, messaging and engagement.

    In this webinar, we’ll discuss how companies who embrace a holistic data and network analytics approach to strategic planning and execution can achieve significant competitive advantage, improved customer engagement and faster market penetration.
  • The evolution of pharma social media intelligence
    The evolution of pharma social media intelligence Paul Tunnah(Moderator); Professor Andrew Stephen (University of Oxford); Anurag Abinashi (IQVIA) Recorded: Nov 23 2017 61 mins
    Is your company a fully mature user of intelligence from social media, or is it still not tapping into insights?

    As shown in the consumer world, social media can be a very rich source of insights into customers and markets, and can provide early signals of new trends. Exactly the same is true for patient and health care provider insights, especially when used with other more traditional data sets.
    But understanding how to engage, and how to extract the right data to get actionable insights – and all the while complying with regulations – isn’t so straightforward.

    Life sciences companies in particular, want to put this new data source in context with its already broad range of metrics. Achieving this calls for a step-by-step progression towards social media maturity.
    pharmaphorum is working in collaboration with experts from IQVIA and Professor Andrew Stephen of Oxford University to deliver a topical debate focussed on this field, intended to provide answers to some of the conundrums the industry faces.

    An expert panel will provide practical advice and real-life examples of how pharmaceutical companies can develop maturity in social media intelligence.

    Increase your understanding of how social media can easily be used to ultimately add value

    Learn the tricks - how, when and why marketers from other sectors use social media channels to their advantage

    Hear how leading pharma organisations have embraced social media and have seen real results
  • UNLEARN. RELEARN. REIMAGINE. Smarter communications through behavioral science
    UNLEARN. RELEARN. REIMAGINE. Smarter communications through behavioral science Andrew McConaghie, David Hogben (Complete HealthVizion), Robert Poole (Complete HealthVizion), Bjarke Ebert (Lundbeck) Recorded: Nov 22 2017 69 mins
    How can we create smarter, more effective communications for HCPs and patients? What can be done to challenge the status quo, apply a different mindset to communications, and deliver the best possible patient outcomes?

    In this webinar, we will discuss how multichannel strategy and behavioural science are natural partners in creating smarter, more meaningful, and more effective communications. The premise is simple: if we apply a behavioural mindset, we can determine where to focus our communications for the best effect, design the most appropriate multichannel strategy and content, and put the right metrics in place to measure success.
  • Radiogenomics in Radiation Oncology: More than Omics
    Radiogenomics in Radiation Oncology: More than Omics Issam El Naqa, PhD, MA, FAAPM Associate Professor Recorded: Nov 22 2017 45 mins
    The webinar will discuss recent progress and potentials of radiogenomics and its role in treatment response modelling as a bridge between dose-response and optimized outcomes.
  • No More LC:  Microextraction Coupled with Direct MS Analysis
    No More LC: Microextraction Coupled with Direct MS Analysis Olga Shimelis, Principal R&D Scientist and R&D Supervisor, Merck KGaA, Darmstadt, Germany Recorded: Nov 16 2017 53 mins
    Mass spectrometry (MS) is an accepted research tool for both academic and industrial laboratories. As MS continues to gain ground in clinical and industrial testing, the requirements for high throughput, high sensitivity and high accuracy analyses put more emphasis on sample preparation. Solid Phase Microextraction (SPME) is well suited for this purpose as it requires minimal sample, provides pre-concentration of analytes, and allows for quantitative determinations.
    This webinar will focus on the use of microextraction devices for direct MS analysis for applications that do not require chromatographic separation. Such analysis often results in very high throughput and more immediate results in comparison to traditional methods. Several Direct MS interfaces will be reviewed. The relevant overview of the literature as applied to the direct MS analysis of microextracted samples will be presented. The presentation also will discuss in more detail the coupling of Direct Analysis Real Time (DART) with a new type of solid phase microextraction devices (known as BioSPME).
  • Simulating Heat Transfer with COMSOL®: Knowing Your Material Properties Webinar
    Simulating Heat Transfer with COMSOL®: Knowing Your Material Properties Webinar Louise Wright, Principal Research Scientist, Data Science Group, NPL and Andrew Young, Applications Engineer, COMSOL Recorded: Nov 16 2017 60 mins
    This webinar is sponsored by: COMSOL and The National Physical Laboratory (NPL)

    If you are interested in correctly handling material properties in heat transfer modelling, then tune into this webinar with Louise Wright from the Data Science Group at the National Physical Laboratory (NPL).

    Heat transfer modelling is used in a wide range of industries and research areas, including materials processing, food manufacturing, power generation, and aerospace. Reliable model results require reliable material properties, but it can be difficult to know how to get suitable values, particularly if the model involves very high or very low temperatures.

    In this webinar, we will discuss NPL’s measurement capabilities for thermal behaviour and how they are extending these capabilities. You will also learn about NPL’s use of heat transfer modelling to design their kit and experiments.

    The webinar will include a live demonstration and conclude with a Q&A session.
  • The Role and Limitations of Sigma Analysis in Lab QC
    The Role and Limitations of Sigma Analysis in Lab QC Jack Montgomery, MLS(ASCP)cm Recorded: Nov 15 2017 54 mins
    Hear Jack Montgomery share his experiences and methodologies in applying sigma analysis to lab quality control at Asante Health, a Truven Health Analytics Top 100 hospital the past four years.

    In this webinar, Jack will discuss the dynamic nature of sigma metrics for clinical chemistry analytes. He will show how they can be improved over time with enhanced monitoring and optimized maintenance schedules. This sensitivity of sigma metrics highlights the notion that sigma methodology is just one of the many tools that should be used for a holistic approach to lab quality.

    By attending this webinar, you will:
    - Understand the practical use of Six Sigma as a lab quality tool
    - Learn about the dynamic nature of sigma metrics and how they can be improved in the lab
    - Gain insights into the additional tools for implementing a multi-faceted total quality program

    P.A.C.E. credit is available for your participation.*

    Presenter:
    Jack Montgomery, MLS(ASCP)cm, is the chemistry technical specialist for Rogue Regional Medical Center—the flagship entity for Asante Health—a growing three-hospital system located in southern Oregon containing a laboratory accredited by the College of American Pathologists. Jack has over 40 years of experience in the clinical laboratory with a special interest in quality control, sigma metrics and method validation.

    *Beckman Coulter, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program. These credits are recognized by the State of California. Most programs also provide State of Florida credits (with valid license number). At this time we cannot issue continuing education credits for those who provide healthcare (or work for an institution that provides healthcare) in Massachusetts or Vermont.
  • The Power of Storytelling in Health: Friend or Foe?
    The Power of Storytelling in Health: Friend or Foe? Dominic Tyer Recorded: Nov 15 2017 51 mins
    With traditional media moving online, and the era of social media driving stories through the ethernet, never has a ‘story’ been more impactful.

    On 15th November JPA Health Communications, in association with PM Group, will debate how a powerful, personal story can surpass facts and figures to create change in a way even the ‘storyteller’ could not have imagined.
  • Can the New generation of perfusion technology compete or replace the convention
    Can the New generation of perfusion technology compete or replace the convention Ankur Bhatnagar & John Bonham-Carter Recorded: Nov 15 2017 76 mins
    Recently, there has been a renewed interest in the field of continuous processing. Some key factors driving this interest are – availability of better cell retention devices, improved cell lines and culture medium capable of supporting high cell densities.

    These factors have contributed mainly in reducing the batch duration for making the required quantity of product, thus reducing the medium requirement and chances of batch failures significantly. With the continuous processing being considered as ‘back-in-the-game’, the question remains: Can the current perfusion technology compete or replace the conventional and widely preferred fed-batch technology?

    Two cases are discussed to compare the performance features of fed-batch and perfusion processes. In both the cases, the product output from perfusion process is significantly higher (2 to 5 folds) than that from fed-batch, due to combination of factors like higher cell density, higher cell specific productivity, lower accumulation of toxic metabolites etc. These cases demonstrate the potential of perfusion process in significantly increasing the product output. However, there are certain challenges and points to be considered before a company decides to switch to a perfusion platform. Some of these are highlighted in the article.
  • RISE -The Complete Picture of Material Properties: Correlative Raman-SEM Imaging
    RISE -The Complete Picture of Material Properties: Correlative Raman-SEM Imaging Dr. Ute Schmidt – Applications Manager at WITec GmbH Recorded: Nov 14 2017 53 mins
    RISE – Raman Imaging and Scanning Electron – microscopy is a correlative approach that combines molecular and ultrastructural analysis. With this hybrid technique, information on the chemical composition of a sample provided by the optical Raman microscope is overlaid onto structural features imaged with a high resolution scanning electron microscope. Both methods can be controlled with software and the correlation carried out while the sample remains under vacuum. The integration of both techniques within a single instrument eliminates the necessity of manually locating the same measurement position, a notoriously time-consuming process with separate instruments.
    In this webinar, the principles of state-of-the-art confocal Raman imaging as a tool for the analysis of molecular characteristics of a sample will be presented, then the manner in which this information can be linked to structural information acquired with scanning electron microscopy will be demonstrated. The advantages of seamless correlative investigation will be described and shown with several examples.
  • iPSCs: The Future of Disease Research
    iPSCs: The Future of Disease Research Dr. Sharon Bahia, Product and Distributor Manager, The European Collection of Authenticated Cell Cultures (ECACC) Recorded: Nov 9 2017 36 mins
    The development of human iPSC technology offers researchers the ability to more accurately generate physiologically relevant models of disease and normal tissues in the laboratory. Advances in iPSC generation have allowed many laboratories to make their own cell lines; however, researchers rarely have the resources needed to establish stocks, undertake quality control and share their own de novo iPSC cell lines with other laboratories. A pre-existing and established iPSC collection therefore allows iPSC researchers to obtain “off the shelf” access to a large, robust and reliable supply of iPS cell lines that represent diverse donor to donor variability and which include disease status normal controls and gene edited cell lines. iPSCs from ECACC are standardised and quality controlled and have the benefit of coming from a trusted and internationally recognised collection with worldwide distribution.
  • Scopus Data for Ranking Organizations
    Scopus Data for Ranking Organizations M'hamed el Aisati, VP Funding, Content & Analytics Recorded: Nov 9 2017 59 mins
    Over the past 10 years, Scopus has emerged as the partner of choice in the fast-developing field of rankings. Join us for a discussion on the importance of A&I data to ranking organizations, and why they choose Scopus.
  • Peer Review and Publishing Ethics- Wiley Learn to Publish Webinar Series
    Peer Review and Publishing Ethics- Wiley Learn to Publish Webinar Series Danielle Chilvers, Leah Webster and Dr Andy Turner Recorded: Nov 9 2017 62 mins
    Learn how to navigate the dos and don’ts of Peer Review and Publishing Ethics.

    In the second of the Wiley Learn to Publish webinar series, we’ll be covering all you need to know to understand the Peer Review process and the basics of Publishing Ethics.
    Hear from our expert editors on:
    -The basics of the peer review process and common models
    -What Reviewers are looking for
    -Possible outcomes and dealing with rejection
    -Your ethical responsibilities as an author
    -Penalties for unethical behaviour
    -Tips for navigating ethical challenges in scholarly publishing
    We’ll also be answering your questions in a live Q&A.
  • Integrated Quality Assurance in Radiation Oncology.
    Integrated Quality Assurance in Radiation Oncology. James P Nunn, MS, CHP, DABR Senior Medical Physicist Radiation Safety Officer LewisGale Hospital Pulaski Recorded: Nov 8 2017 61 mins
    Approved for one credit for CAMPEP, MDCB, ASRT

    As radiation-oncology clinics transition from paper to paperless environments, more documentation is being stored in computer databases. Medical-physics documentation was traditionally stored in large binders on a bookshelf and disparate Excel files on a PC hard drive. Historically this was the only option for storing the large volume of data required for regulatory compliance. In the last 5 years many vendors of radiation-oncology quality-assurance (QA) equipment have stepped up to fill this gap. Additionally, QA software is now available that combines the interfacing of hardware with QA systems. In this lecture I will cover some of the software packages available from vendors and will share the LewisGale experience in implementing one software package for integrated QA. I will conclude the lecture with some of my personal thoughts regarding suggestions for QA software vendors for the future.
  • Patent Monetisation: Markets, Litigation and Legislation
    Patent Monetisation: Markets, Litigation and Legislation David Pridham and Brad Sheafe from Dominion Harbor and Jessie Parker from PatSnap Recorded: Nov 8 2017 59 mins
    David Pridham, Chief Executive Officer and Brad Sheafe, Chief Intellectual Property Officer of Dominion Harbor will be taking us through their recent acquisition of the Kodak Patent Portfolio and the steps they are taking to monetise over 4000 patents.

    Unfortunately patent monetisation isn't as simple as selling or licensing, it depends heavily on the other players in the market, where the market is moving and also the litigation and future legislation when it comes to that particular technology.

    This webinar will cover:

    - The analytical approach (using technology to help assess the opportunity)
    - The go-to-market strategy development
    - How to present this strategy to potential buyers without being exposed to litigation risks
    - Building global partnerships to maximise the monetisation potential of the portfolio in a heterogeneous, world-wide marketplace
    - Managing prosecution, maintenance, divestiture and abandonment
  • Promoting your research with impact: understanding journal metrics and SEO
    Promoting your research with impact: understanding journal metrics and SEO Dr Andrew Moore Dec 13 2017 9:30 am UTC 60 mins
    Maximise the impact of your published work! Find out more about sharing and promoting your research including SEO and Altmetrics.
    You'll learn about:
    -Title, Abstract and Keyword best practices
    -Tips for building links
    -Understanding Impact Factors and Altmetrics
    -Tools and resources available to help you share and promote your work
    Learn from and interact with the Editor-In-Chief for the Wiley Researcher Academy, Dr Andrew Moore. You’ll have the chance to ask questions during the live Q&A sessions and connect with other researchers in the BrightTalk community.
  • 2018 Global Healthcare Market Predictions Revealed
    2018 Global Healthcare Market Predictions Revealed Reenita Das, Partner, Kamaljit Behera, Industry Analyst, Neil Jordan, Microsoft, Kay Eron, Intel, Keith Bigelow,GE Healthcare Dec 13 2017 3:00 pm UTC 60 mins
    2018 will be a tipping point for mainstream adoption of popular digital health technology solutions such as artificial intelligence, mHealth/wearables, telehealth, Big Data analytics, and robotics. The transition of technologies from ideation to actionable applications will drive new opportunities across the globe.

    From data monetization unleashing the power of patient data to digital transformation of patient monitoring, there will be growing awareness of current inefficiencies and new opportunities identified to improve the efficiency of healthcare delivery.
  • Transforming Access to Medicines Through Patient-Centric Solutions
    Transforming Access to Medicines Through Patient-Centric Solutions Dominic Tyer Dec 14 2017 2:00 pm UTC 60 mins
    As medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are operating optimally.

    To do this Inceptua Medicines Access and patient group, HAEi, in association with PMGroup, will host a free webinar on Thurday 14th December that will cover both the pre-approval access to medicines and the importance of putting patients at the heart of drug development and access.

    Pre-approval access - a transformational approach
    There are a number of factors at play within the world of medicines access: from industry who need to navigate requests for their pre-approval and unlicensed medicines, to healthcare professionals who are looking for options for their patients and ultimately to the patients and patient advocacy groups who are more empowered than ever and are driving for more timely access to treatments. Today’s healthcare, political and regulatory environments burden have generated a rapid, increasing and significant expansion in the need for access to these medicines. Mark Corbett, Executive Vice President at Inceptua Medicines Access talks about the company’s transformative approach to medicines access, designed to rise to the evolving challenges of the environment, offering unsurpassed understanding and insight into the needs of biopharmaceutical companies and healthcare organisations.

    Patients at the heart of drug development and access
    If you believe the news every day, patients are becoming more and more involved in drug development and access pathways, but what does this mean in reality
  • Rapid Fontana-Masson Staining
    Rapid Fontana-Masson Staining Vikas Palhan, PhD, Senior R&D Scientist, Emerging Biology - Genomics Dec 14 2017 3:00 pm UTC 75 mins
    In the continued effort to save you time and simplify your workflow, we’ve developed a Fontana-Masson Staining Kit with a protocol that is 30x faster than the standard protocol. In this webinar, the researcher who developed the kit explains how easy it is to use this new rapid microwave technique. If you need to stain melanin and argentaffin cells in tissue sections, take a few minutes to watch this webinar - and save yourself many more minutes in the future by using this kit.
  • Total Nitrogen Test Kits as an Alternative to TKN, Nitrate, and Nitrite Tests
    Total Nitrogen Test Kits as an Alternative to TKN, Nitrate, and Nitrite Tests Taylor Reynolds; Ed Askew Ph.D. Dec 14 2017 5:00 pm UTC 75 mins
    Currently the US EPA has not promulgated a method for the analysis of Total Nitrogen (TN). Most states that have TN regulations require permitee's to measure TN as the composite of TKN, Nitrate and Nitrite. This approach is costly, time consuming, and also susceptible to variability based on the methods used for the individual analytes Merck, KGaA, Darmstadt, Germany is excited to announce the introduction of a Total Nitrogen Test Method consisting of a single spectrophotometric test kit. The method has been evaluated in a multilab study and this webinar will present the results of that study as well as an overview of the savings made possible by utilizing this new method for testing Total Nitrogen.
  • Plan Explorer; An Automated Treatment Planning Approach
    Plan Explorer; An Automated Treatment Planning Approach Björn Hårdemark, Deputy CEO, RaySearch Laboratories Dec 20 2017 4:00 pm UTC 60 mins
    Plan Explorer provides a new paradigm in treatment planning. This talk goes through the underlying algorithms, explains how to use the system, gives examples of plan configurations and provides an outlook into future developments of this feature found within the RayStation treatment planning software.
  • Publishing Ethics: understanding the dos and don’ts of research publishing
    Publishing Ethics: understanding the dos and don’ts of research publishing Dr Andrew Moore Jan 5 2018 9:30 am UTC 60 mins
    Understand the ethics of publishing your research in this interactive webinar. You'll learn about:
    -Your ethical responsibilities as an author
    -Penalties for unethical behaviour
    -Tips for navigating ethical challenges in scholarly publishing
    Learn from and interact with the Editor-In-Chief for the Wiley Researcher Academy, Dr Andrew Moore. You’ll have the chance to ask questions during the live Q&A sessions and connect with other researchers in the BrightTalk community.
  • Towards Real Time Release testing: Dissolution prediction of tablets made using
    Towards Real Time Release testing: Dissolution prediction of tablets made using Dr Erik Skibsted Jan 10 2018 3:00 pm UTC 75 mins
    After 50 years of near-stagnation, pharmaceutical manufacturing is experiencing unprecedented scientific and technological innovation. There is a paradigm shift from testing product quality using lengthy off-line (and after-the-fact) assays to quality being tested during the process using online/ at-line measurements. This ability to evaluate and ensure quality of final product based on process data, geared towards making batch release decisions, is known as real time release testing (RTRt). A case study for predicting dissolution profiles of tablets made using CDC is presented. The methodology enables real-time release testing. Four different parameters were varied in the CDC line; API concentration, blender speed, feed frame speed, and compaction force, and their effect on tablet dissolution was investigated. Model dependent and model independent approaches were used to extract information from dissolution profiles. Multivariate regression was built between the information obtained from the NIR as the predictor variables and the dissolution profile parameters as the response. This enabled prediction of dissolution profiles for test samples made using CDC. Alternative RTRt approaches towards dissolution prediction will also be discussed.
  • Introduction to searching/using Markush structures from Patents
    Introduction to searching/using Markush structures from Patents Ruta Sudmantaite @ PatSnap Jan 10 2018 4:00 pm UTC 60 mins
    Chemical Patents are often very long and difficult to read. Markush searching can enable you to easily categorize and filter the information you need, giving you the insights that a paper sometimes cannot.

    In this webinar you will learn:

    -How to get started with patent search
    -Basic patent language you need to be aware off
    -How to create Markush searches to yield the best results when researching.
    -Benefits of patent search for your processes
  • Estimating respiratory rate from the electrocardiogram and photoplethysmogram
    Estimating respiratory rate from the electrocardiogram and photoplethysmogram Dr Peter H. Charlton Research Associate, King’s College London Jan 16 2018 2:00 pm UTC 45 mins
    Respiratory rate (RR) is a key physiological parameter that is used in a range of clinical settings for diagnosis and prognosis. Despite its importance, it is usually measured by hand. Over the past 50 years many techniques have been developed to estimate RR from two widely acquired physiological signals: the electrocardiogram (ECG) and the pulse oximetry signal (photoplethysmogram (PPG)). Although these techniques have been the subject of much research, they have not yet been widely integrated into clinical practice. This webinar will provide a comprehensive overview of the state of the art in estimating RR from the ECG and PPG. It is intended to equip researchers with the knowledge and tools to translate this promising technology into patient benefit.
  • Enabling comprehensive data analytics and process monitoring in Biomanufacturing
    Enabling comprehensive data analytics and process monitoring in Biomanufacturing Robert Dimitri, Hugo Guerra and Gloria Gadea-Lopez, Ph. D Jan 17 2018 3:00 pm UTC 75 mins
    Technical teams rely on the availability of meaningful data and effective tools to perform process monitoring, to conduct root cause analysis and investigations and, most of all, to obtain new insights into their operations. In this article, the authors discuss the implementation and management of a comprehensive system for data analytics at Shire –Lexington, MA site, the lessons learned, and practical advice towards the successful deployment of these key applications.
  • The Future of the United States Medical Imaging Industry
    The Future of the United States Medical Imaging Industry Tanvir Jaikishen, Senior Research Analyst - Transformational Health, Frost & Sullivan Jan 23 2018 4:00 pm UTC 60 mins
    The US medical imaging industry is transforming to cope with the challenges of the present and the demands of the future. The current care provision landscape is highly fragmented, and a coherent strategy is required to enhance interoperability among stakeholders across the imaging ecosystem. This is essential to bring about standardization of the care protocols, development of new industry best practices and improvement of workflow productivity—essential prerequisites toward improving the efficiency of care provision, improving patient outcomes and lowering costs. Stakeholders across the industry must also come together to eliminate redundancies and duplications, and streamline the imaging process, to improve the patient experience. Market participants need to work more collaboratively with care providers to address unmet needs and develop technologies and solutions that help care providers address regulatory and reimbursement compliances without having to invest in additional manpower and resources.
  • Disposables – Suitability and Process Economy In Biopharmaceutical Manufacturing
    Disposables – Suitability and Process Economy In Biopharmaceutical Manufacturing Dr Joachim Walter Jan 24 2018 3:00 pm UTC 75 mins
    Since the introduction of disposables and gaining popularity of Single-use Technology (SUT) for biopharmaceutical manufacturing there is nevertheless an ongoing controversial discussion on the advantages and disadvantages versus a conventional stainless steel environment.

    In a “classical” facility design any validation cost effort can easily be distributed to a considerable number of production runs thus contributing only to a non-decisive amount to the overall production costs. The scale for such plant is nearly unlimited as is the scale of operation. The “flexible” approach using disposables and single-use equipment offers significant advantages regarding changeover work and time thus a high throughput of different processes will definitely take profit as any cleaning and related validation and costly analytics doesn’t apply to a larger extent.

    Despite the potential benefits loudly advertised by the respective industry, these potential advantages derived from single-use equipment and disposables can be significantly diminished by lack of detailed process cost analysis, missing economic analysis and cost comparison between conventional and SU technologies as well as underestimating the cost of long term dependency on consumables. Due to missing appropriate standards, there is a widely non-compatibility between the equipment and consumables of the various suppliers, resulting in a strong dependence on the consumables of a single supplier once a single-use equipment has been purchased, curiously leaving some customers with surprise that they hardly have any room for price negotiations on the required consumables.
    This paper’s focus is on the very different arguments for the application of SU equipment and consumables, including advantages and limitations of SUT, understanding improvement of process robustness, contribution to lean production as well as environmental impact of disposables.
  • The Path to Cost-Effective Turnkey Object Storage
    The Path to Cost-Effective Turnkey Object Storage Vas Vasiliadis, Chief Customer Officer, Globus Jan 25 2018 6:00 pm UTC 45 mins
    For research data to be truly useful, it must be easy to access, share and manage without requiring expensive, custom infrastructure. What organizations need is turnkey storage that won't break the bank, with a unified interface for fast, reliable data transfer and sharing. This webinar introduces Globus for ActiveScale, a cost-effective solution for on-premise object storage that’s simple to deploy and use. With Globus for ActiveScale, researchers have access to advanced capabilities for managing data across a broad range of systems, while administrators gain a cost-effective, scalable, and durable solution they can deploy quickly to help their researchers innovate faster. In this webinar, attendees will learn how to deploy and use Globus for ActiveScale -- the session includes a product demonstration and a Q&A session with the Globus Chief Customer Officer.
  • Sharing and Promoting your Research- Wiley Learn to Publish Webinar Series
    Sharing and Promoting your Research- Wiley Learn to Publish Webinar Series Jennifer Deroche, Anna Smart and Katy Dillon Jan 31 2018 9:30 am UTC 60 mins
    Maximise the impact of your published work! Find out more about sharing and promoting your research including SEO and Altmetrics.

    In the third and final webinar in our Learn to Publish series, our expert editors and marketers will cover:
    -What you need to do to get read, get shared and get cited
    -SEO in 4 easy steps
    -Title, Abstract and Keyword best practices
    -Tips for building links
    -Understanding Impact Factors and Altmetrics
    -Tools and resources available to help you share and promote your work
    We’ll also be answering your questions in a live Q&A.
  • Venezia – Reaching Beyond
    Venezia – Reaching Beyond Matthew Biagioli, MD Feb 5 2018 3:00 pm UTC 60 mins
    Treating advanced-stage cervical cancer can be difficult without the right tools. Dr Matthew Biagioli will discuss a new option for reaching beyond the current constraints with the Venezia applicator for reproducible results and seamless integration into your current workflow.
  • Do Extractable Protocols Truly Help- An End User Perspective
    Do Extractable Protocols Truly Help- An End User Perspective Ekta Mahajan, Genentech/Roche Feb 5 2018 3:00 pm UTC 75 mins
    Single Use technology is being used more each year in the biotechnology industry. However, extractables and their potential impact on product and patients continue to be one of the biggest challenges. The challenge is augmented by the lack of standardized methodology for suppliers to execute extractable studies that meets end user requirements. The end users are responsible and required by law to assess the impact of extractables and leachables on overall Product Quality and Safety. Due to lack of a standard, customized data had to be generated for/by each end users. This resulted in long lead times, higher costs and inefficient utilization of resources. Typically, the data generation and qualification of single use component can take up to a year, which can impact implementation of single use. BioPhorum Operations Group (BPOG) developed a standardized protocol9 for generating extractable data that would meet user requirements and simplify/reduce implementation time within industry. A standardized protocol gives confidence to suppliers that testing performed by them would meet end user requirements and enable faster implementation. Some suppliers shared the BPOG vision and proactively tested their single use components using BPOG protocol, which has helped expedite the use of their products.
  • Efficient execution of biologics manufacturing – The role of Finite Scheduling
    Efficient execution of biologics manufacturing – The role of Finite Scheduling Gloria Gadea-Lopez, Ph.D., John Maguire and Gerry Glennon Feb 14 2018 3:00 pm UTC 75 mins
    The success of manufacturing relies on the availability of all the resources –personnel, materials, equipment, work instructions - , orchestrated in such a way that the operations proceed in an efficient and predictable manner. This article describes the implementation of a finite scheduling system for biologics production, the foundational work required prior to project launch, lessons learned, and benefits achieved from this deployment.
  • Functional collaborations required to successfully validate a Mab process at a C
    Functional collaborations required to successfully validate a Mab process at a C Harish Santhanam Feb 28 2018 3:00 pm UTC 75 mins
    Technology transfer leading to a successful validation of a Monoclonal Antibody process at a CMO site is a complex task that would need seamless interaction between various functions of the sending and receiving organizations. The success of the process is very much dependent on the technical depth, personal trust and the strength of the relationships established between the team members across the various functions in both organizations. The interactions begin with the due diligence process and builds through laboratory scale technology transfer leading to engineering/GMP campaigns and ends with a successful validation.  Depending on the stage in development of the molecule being technology transferred, the sending organizations could have personnel involved from both development and manufacturing making the process more complex. This write up will outline the role played by the various functions starting from Technical Services to Quality Assurance and will include functions like Shipping and Supply Chain.
  • Making patent searches more effective with Boolean
    Making patent searches more effective with Boolean Dvorah Greaser from KISSPatents and Ruta Sudmantaite @ PatSnap Feb 28 2018 4:00 pm UTC 45 mins
    Patent searching is something most IP counsel is very familiar with. It's your day to day when looking at Freedom to Operate, competitive analysis and portfolio management.

    However, it can be hard to predict what you need in a search when you are not a technical expert. In this webinar, we will teach you how to construct the most effective searches using boolean and a few other tips and tricks on how to ensure you include all the technical detail you need.
  • Process analytical Technology for Upstream Bioprocessing
    Process analytical Technology for Upstream Bioprocessing Erica Fratz-Berilla & LCDR Agarabi Mar 5 2018 3:00 pm UTC 75 mins
    In commercial cell culture bioprocessing, consistent high quality protein is a fundamental goal that is typically accomplished during development through product and process engineering of bioreactor parameters. The FDA’s Center for Drug Evaluation and Research (CDER)’s Office of Biotechnology Products’ upstream bioprocessing laboratory, a part of the Office of Pharmaceutical Quality’s Center of Excellence (COE) in Manufacturing Science and Innovation, studies Process Analytical Technology (PAT) for upstream bioprocessing, focusing on the production of monoclonal antibodies. These capabilities are being leveraged to study continuous bioreactor cell culture production and compatible PAT tools. Case studies are presented that illustrate collaborative laboratory research being conducted on PAT tools for upstream bioprocessing to support regulatory decision making.
  • Application of Multivariate Data Analysis for Process Diagnostic and Root Cause
    Application of Multivariate Data Analysis for Process Diagnostic and Root Cause Ramila Peiris, Ph.D., Manager, Process Modelling and Process Analytical Technology, Sanofi Pasteur Mar 7 2018 3:00 pm UTC 75 mins
    The utilization of Multivariate Data Analysis (MVDA) techniques at Sanofi Pasteur, Toronto site has demonstrated innovative capabilities for improved process understanding, control and diagnostics. Examples from several successful and high impact applications will be presented. These examples cover the application of MVDA techniques in multivariate process control, root cause investigations and process analytical technology (PAT). The areas of application include fermentation, downstream purification and product formulation stages.
  • Project and Portfolio Management as a key tool to manage continuous improvement
    Project and Portfolio Management as a key tool to manage continuous improvement Gloria Gadea-Lopez, Ph.D.and Melvin Santos Mar 14 2018 2:00 pm UTC 75 mins
    Continuous improvement, risk mitigation and adherence to compliance rely on the successful execution of key initiatives aligned with an organization’s strategic imperatives. This article summarizes the Project and Portfolio initiatives at Shire’s Biologics manufacturing facility at Shire, Lexington, MA site. In addition to practical advice, the authors discuss the need for sound business processes, alignment with Finance and budget cycles, and play special attention to the importance of resource allocation and management.
  • Using patent data to accelerate your Time to Market
    Using patent data to accelerate your Time to Market Ruta Sudmantaite @ PatSnap Mar 14 2018 4:00 pm UTC 60 mins
    Time to Market is an essential metric that R&D teams are measured on. This becomes even more important when we are talking about patented chemicals and processes within the Medical, Pharma and Lifesciences.

    If your competitor beats you to market all the time and money spent on research and development becomes a sunk cost, but how can data change that for you?

    Using patent and journal data you can give your research teams the tools to quickly validate ideas and decide if they are worth pursuing and simultaneously remove the bottleneck that is placed on Data Analysts.

    Join this webinar to learn how data can be applied to research and how this could cut costs and reduce time to market.